ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 541

An Essential Role For Caspase-1 In The Induction Of Murine Lupus and Its Associated Vascular Damage

J. Michelle Kahlenberg1, Srilakshmi Yalavarthi2, Wenpu Zhao2, Jeffrey Hodgin3, Tamra J. Reed4, Noriko M. Tsuji5 and Mariana J. Kaplan6, 1Internal Medicine, Division of Rheumatology, University of Michigan, Ann Arbor, MI, 2University of Michigan Rheumatology, Ann Arbor, MI, 3Department of Pathology, University of Michigan, Ann Arbor, MI, 4Internal Medicine, Rheumatology, University of Michigan, Ann Arbor, MI, 53Biomedical Research Institute, National Institute of Advanced Industrial Science and Technology, Tsukuba, Japan, 6Systemic Autoimmunity Branch, National Institutes of Health/NIAMS, Bethesda, MD

Meeting: ACR/ARHP Annual Meeting 2013

Keywords: autoantibodies, inflammasome activation, interferons and nephritis, Lupus

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Title: Systemic Lupus Erythematosus - Animal Models

Session Type: Abstract Submissions (ACR)

Background/Purpose: Systemic Lupus Erythematosus (SLE) is a systemic autoimmune syndrome associated with organ damage and an elevated risk of cardiovascular disease (CVD) resulting from activation of both innate and adaptive immune pathways.  Recently, increased activation of the inflammasome machinery in SLE has been described. This study explores if caspase-1, the central enzyme of the inflammasome, plays a role in the development of SLE and its associated vascular dysfunction, using the pristane model of lupus. 

Methods: Eight-week old wild-type or caspase-1 -/- mice were exposed to PBS or pristane via intraperitoneal injection.  Six months post injection, mice were euthanized and the development of a lupus phenotype and vascular dysfunction was assessed. 

Results: Both wild-type and caspase-1 KO mice develop a vigorous inflammatory response to pristane; however, cell death following pristane exposure is decreased in caspase-1 -/- mice.  While wild-type mice exposed to pristane develop autoantibodies and a strong type I IFN response, mice lacking caspase-1 are significantly protected from these features, including pristane-induced vascular dysfunction.  Further, the development of immune-complex glomerulonephritis, prominent after pristane exposure in wild-type mice, is significantly abrogated in caspase-1 -/- mice. 

Conclusion: These results indicate that caspase-1 is an essential component in the development of lupus and its associated vascular dysfunction following exposure to pristane.  Importantly, caspase-1 may modulate autoantigen generation through regulation of cell death.  Thus, caspase-1 may play an important role in the cross-talk between environmental exposures and autoimmunity development, providing a novel pathway for therapeutic targeting.


Disclosure:

J. M. Kahlenberg,
None;

S. Yalavarthi,
None;

W. Zhao,
None;

J. Hodgin,
None;

T. J. Reed,
None;

N. M. Tsuji,
None;

M. J. Kaplan,
None.

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to ACR/ARHP Annual Meeting 2013

ACR Meeting Abstracts - https://acrabstracts.org/abstract/an-essential-role-for-caspase-1-in-the-induction-of-murine-lupus-and-its-associated-vascular-damage/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology